Physician profile
Jonathan C Ellis
NPI 1306876263
$13,290.03
in general payments reported to CMS, 2019-2025
43 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,775 · 2020: $267 · 2021: $3,226 · 2022: $3,963 · 2023: $2,684 · 2024: $1,151 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,012 · Education: $46.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,012.07 |
| Education | $46.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $3,523.64 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Abbvie INC. | $2,212.17 | 2019-2024 | |
| Janssen Biotech, INC. | $1,085.31 | 2019-2024 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $952.05 | 2019-2025 | Entyvio, Gattex |
| Qol Medical, LLC | $597.94 | 2019-2025 | Sucraid, Sucraid |
| Ferring Pharmaceuticals INC. | $582.34 | 2019-2022 | |
| Shire North American Group INC | $500.00 | 2019 | |
| Redhill Biopharma INC. | $401.98 | 2021-2024 | Talicia, Movantik, Aemcolo |
| Nestle Healthcare Nutrition INC. | $353.18 | 2020-2023 | |
| Ardelyx, INC. | $325.47 | 2022-2023 | Ibsrela |
| Merck Sharp & Dohme LLC | $317.38 | 2019-2024 | Dificid |
| Celgene Corporation | $302.60 | 2021-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $224.31 | 2021-2024 | Linzess |
| Intercept Pharmaceuticals, INC. | $177.36 | 2019-2025 | |
| Genzyme Corporation | $168.93 | 2022-2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.